Understanding how TCAB1 helps assemble telomerase for cell division and cancer treatment.
Defining the role of TCAB1 and its phase separation in telomerase assembly.
This study is looking at a protein called TCAB1 to see how it helps build telomerase, which keeps our chromosomes healthy, and it's for people interested in finding new treatments for aging-related diseases or certain types of cancer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Michigan State University NIH-funded |
| Lab location | 1 site (East Lansing, United States) |
| Project ID | NIH-10897259 on NIH RePORTER |
What this research studies
This research investigates the role of TCAB1, a protein involved in the assembly of telomerase, which is crucial for maintaining the ends of chromosomes called telomeres. Telomeres shorten with each cell division, and when they become too short, cells can stop dividing or die. By studying TCAB1's function, the research aims to develop targeted therapies that could either enhance telomerase activity to combat premature aging diseases or inhibit it to treat cancers where telomerase is overactive. The approach includes biochemical assays and cellular models to understand the mechanisms at play.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with premature aging diseases like Dyskeratosis Congenita or certain types of cancer that exhibit high telomerase activity.
Not a fit: Patients with conditions unrelated to telomere shortening or telomerase dysfunction may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for diseases associated with aging and cancer.
How similar studies have performed: Other research has shown promising results in targeting telomerase for cancer treatment, indicating that this approach has potential for success.
Where this research is happening
East Lansing, United States
- Michigan State University — East Lansing, United States (Active)
Researchers
- Principal investigator: Schmidt, Jens Christopher — Michigan State University
- Study coordinator: Schmidt, Jens Christopher
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.